These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1555493)

  • 21. A new physiologically based, segregated-flow model to explain route-dependent intestinal metabolism.
    Cong D; Doherty M; Pang KS
    Drug Metab Dispos; 2000 Feb; 28(2):224-35. PubMed ID: 10640522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic galactose elimination kinetics in the intact pig.
    Keiding S; Johansen S; Winkler K
    Scand J Clin Lab Invest; 1982 May; 42(3):253-9. PubMed ID: 7134810
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of pharmacokinetic models of hepatic elimination.
    Morgan DJ; Smallwood RA
    Clin Pharmacokinet; 1990 Jan; 18(1):61-76. PubMed ID: 2178850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experimental studies of transient mass transfer and reaction in the liver: interpretation with a heterogeneous compartment model.
    Saville BA; Gray MR; Tam YK
    J Pharm Sci; 1992 Mar; 81(3):265-71. PubMed ID: 1640366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the novel in vitro systems for hepatic drug clearance and assessment of their predictive utility.
    Houston JB; Rowland-Yeo K; Zanelli U
    Toxicol In Vitro; 2012 Dec; 26(8):1265-71. PubMed ID: 22244922
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Representative Sinusoids for Hepatic Four-Scale Pharmacokinetics Simulations.
    Schwen LO; Schenk A; Kreutz C; Timmer J; Bartolomé Rodríguez MM; Kuepfer L; Preusser T
    PLoS One; 2015; 10(7):e0133653. PubMed ID: 26222615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Models of hepatic elimination: comparison of stochastic models to describe residence time distributions and to predict the influence of drug distribution, enzyme heterogeneity, and systemic recycling on hepatic elimination.
    Roberts MS; Donaldson JD; Rowland M
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):41-83. PubMed ID: 3373419
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of mass balance principles to describe regional drug distribution and elimination.
    Upton RN; Mather LE; Runciman WB; Nancarrow C; Carapetis RJ
    J Pharmacokinet Biopharm; 1988 Feb; 16(1):13-29. PubMed ID: 3373417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A compartmental model of hepatic disposition kinetics: 1. Model development and application to linear kinetics.
    Anissimov YG; Roberts MS
    J Pharmacokinet Pharmacodyn; 2002 Apr; 29(2):131-56. PubMed ID: 12361240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the degree of solute mixing in liver models of drug elimination.
    Weiss M
    J Pharmacokinet Biopharm; 1997 Jun; 25(3):363-75. PubMed ID: 9474533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.
    Rivory LP; Roberts MS; Pond SM
    J Pharmacokinet Biopharm; 1992 Feb; 20(1):19-61. PubMed ID: 1588503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical Analysis of Hepatic Clearance Based on an Advection Mass Transfer Model and Mass Balance.
    Kochak GM
    J Pharm Sci; 2020 Jun; 109(6):2059-2069. PubMed ID: 32007506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanistic modeling of drug elimination by the liver using local volume averaging method.
    Izadifar M; Baik OD; Alcorn J
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():4314-7. PubMed ID: 22255294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pharmacokinetics model for targeted drug delivery systems].
    Zhang Z; Liao G; Liu P
    Hua Xi Yi Ke Da Xue Xue Bao; 1993 Mar; 24(1):49-53. PubMed ID: 8340092
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using partition analysis as a facile method to derive net clearances.
    Korzekwa K; Yadav J; Nagar S
    Clin Transl Sci; 2022 Aug; 15(8):1867-1879. PubMed ID: 35579201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic elimination: effect of blood flow on hepatic extraction.
    Chiou WL
    J Pharmacokinet Biopharm; 1987 Dec; 15(6):687-90. PubMed ID: 3450850
    [No Abstract]   [Full Text] [Related]  

  • 37. Multifactorial modeling, drug interactions, liver damage and aging.
    Wosilait WD; Luecke RH
    Gen Pharmacol; 1988; 19(2):143-51. PubMed ID: 3280396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic elimination of flowing substrates: the distributed model.
    Bass L; Robinson P; Bracken AJ
    J Theor Biol; 1978 May; 72(1):161-84. PubMed ID: 661331
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemical substance kinetics in the case of chronobiological variations of elimination rate.
    Merabet-Atmani G; Aliguechi-Bouhadja S; Redouane A; Filali T; Mansour K
    Eur J Drug Metab Pharmacokinet; 1999; 24(4):293-7. PubMed ID: 10892890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Convection-dispersion modeling of hepatic elimination.
    Bass L
    J Pharm Sci; 1986 Mar; 75(3):321-2. PubMed ID: 3701621
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.